Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection.

Abstract

OBJECTIVE:

The impact of statin therapy on cardiovascular outcome in coronary artery disease (CAD) patients with aortic aneurysm or dissection (AD) is still unclear. The aim of this study was to elucidate the effect of statins at discharge to improve outcomes in CAD patients with AD.

METHODS:

Among 14,834 consecutive patients who underwent first coronary revascularization in the CREDO-Kyoto PCI/CABG registry, we identified 699 patients (4.7%) with AD. The primary outcome measure was defined as a composite of all-cause death, myocardial infarction, and stroke. The effect of statin therapy was assessed by a Cox proportional hazards model incorporating clinically relevant factors.

RESULTS:

The risk for the primary outcome measure was significantly higher in patients with AD (adjusted hazard ratio [HR], 1.43; 95% confidence interval [CI], 1.23-1.66; P < .0001). In patients with AD, 215 patients (31%) had already undergone aneurysm repair, and only 274 patients (39%) were treated with statins at discharge. Patients treated with statins were younger, had higher body mass index, and were more often treated with percutaneous coronary intervention. Heart failure, anemia, and hemodialysis were more prevalent in patients treated without statins. In patients without AD, 7014 patients (50%) were treated with statins. Patients treated with statins were younger and had higher body mass index, and more patients were treated for CAD due to myocardial infarction. Heart failure, prior stroke, hemodialysis, anemia, and malignant disease were more prevalent in patients treated without statins. The use of statins was associated with lower risk for the primary outcome measure in patients with AD (adjusted HR, 0.71; 95% CI, 0.51-0.99; P = .045) as well as in patients without AD (adjusted HR, 0.79; 95% CI, 0.73-0.85; P < .0001). The effect size of statin use was similar between the patients with AD and those without AD (P interaction = .69).

CONCLUSIONS:

CAD patients with AD had significantly higher long-term risk for cardiovascular events. Statin therapy was associated with lower risk for cardiovascular events in patients with CAD with AD as well as in patients without AD.

• Authors: Junichi Tazaki, Takeshi Morimoto, Ryuzo Sakata, Hitoshi Okabayashi, Fumio Yamazaki, Noboru Nishiwaki, Kazuaki Mitsudo, Takeshi Kimura, CREDO-Kyoto PCI/CABG registry cohort-2 investigators
• Journal: Journal of vascular surgery (J Vasc Surg) Vol. 60 Issue 3 Pg. 604-12.e2 (Sep 2014) ISSN: 1097-6809 [Electronic] United States
• PMID: 24797553 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2014 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Chemical References

• Hydroxymethylglutaryl-CoA Reductase Inhibitors

Topics

• Aged
• Aged, 80 and over
• Aortic Dissection (diagnosis, epidemiology, mortality)
• Aortic Aneurysm (diagnosis, epidemiology, mortality)
• Chi-Square Distribution
• Comorbidity
• Coronary Artery Bypass
• Coronary Disease (diagnosis, mortality, therapy)
• Female
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)
• Japan (epidemiology)
• Kaplan-Meier Estimate
• Male
• Middle Aged
• Myocardial Infarction (etiology)
• Patient Discharge
• Percutaneous Coronary Intervention
• Prevalence
• Proportional Hazards Models
• Registries
• Risk Assessment
• Risk Factors
• Stroke (etiology)
• Time Factors
• Treatment Outcome